Protara Therapeutics Inc
TARA
NASDAQ
Biotechnology
$3.97
USD
+0.03 (+0.76%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $233.72M
Volume 332.9K
Price Target
$28.00 – $28.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $28.00 and a min estimate of $28.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$28.00
+$1.5 vs prior
Implied Upside
+605.3%
+37.8% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Leland Gershell | Oppenheimer | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
AKBA
Akebia Therapeutics Inc
$0.8700
▲ +0.4%
ARCT
Arcturus Therapeutics Holdings Inc
$8.23
▲ +4.7%
CNXU
Conexeu Sciences Inc
$8.90
▲ +11.7%
ORGO
Organogenesis Holdings Inc
$1.79
▲ +1.7%
ALEC
Alector Inc
$1.96
▼ -3.9%
NBP
NovaBridge Biosciences
$1.96
▲ +3.2%
RCEL
AVITA Medical Inc
$7.85
▼ -2.0%
RNA
Atrium Therapeutics Inc
$12.84
▲ +4.1%
IMUX
Immunic Inc
$16.06
▼ -3.1%